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Abstract
Recent advances in optical coherence tomography (OCT) technology have allowed the 
introduction of OCT into the operating room. Intraoperative OCT (iOCT) has been uti-
lized to visualize the retinal architecture prior, during, and following several retinal surgi-
cal technics. The identification of epiretinal, subretinal, and intraretinal changes is one of 
the crucial points in PVR management. The iOCT can identify intraretinal changes and/
or subretinal PVR membranes which cannot be easily peeled as epiretinal membranes. 
Intraretinal forms are especially difficult to identify preoperatively but their presence may 
be crucial in surgical management because the attempt to remove the presumed mem-
brane may result in severe retinal tissue damage and iatrogenic tears. Therefore, surgical 
technique and even tamponade choice may be seriously affected by OCT imaging results.
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1. Introduction
Optical coherence tomography (OCT) has dramatically changed the diagnosis, classification, 
and treatment of many vitreo-retinal diseases [1–3]. One of the most recent developments of 
this technology is the intraoperative OCT (iOCT). The iOCT allows a real-time tomographic 
visualization of the retina without the need to stop the surgery and without any external 
machines (microscope-integrated OCT). In this way, the surgeon can see OCT images during 
the surgery on an external display or directly through the microscope.
iOCT adds microscopic information and visualizes sub-surface structures in a non invasive 
way. This information can impact surgical decision-making as well as surgical maneuvers in 
selected cases. In this sense, the intraoperative visualization of the retina opens new surgical 
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and diagnostic possibilities. Vitreo-retinal interphase diseases may especially benefit from 
iOCT spreading but also retinal detachment (RD) surgery could be positively affected.
Proliferative vitreoretinopathy (PVR) is one of the most severe complications after RD, 
appearing in 5–10% of them [4]. Despite recent advances in vitreo-retinal surgery, PVR man-
agement is still an unsolved issue [4]. The introduction of the iOCT in surgical practice could 
be useful in improving the management of this important complication.
2. Intraoperative optical coherence tomography (iOCT)
The iOCT is a relatively new technology, and the first relevant study about iOCT applica-
tions in ophthalmology was the so named Prospective Intraoperative and Perioperative 
Ophthalmic Imaging with Optical Coherence Tomography (PIONEER) study [5]. The 2-year 
results published in 2014 demonstrated the potential advantages and applications of this 
technology [5]. Nevertheless, in this study, an external OCT system mounted on the operative 
microscope (Bioptigen SDOIS portable spectral-domain OCT [SD OCT] system; Bioptigen, 
Research Triangle Park, North Carolina, USA) was used. The most serious inconvenience of 
this system was the need to pause the surgery to obtain the required images.
Since this study, relevant advances in this technology have been reached to obtain a real 
microscope-integrated technology. Actually, there are several iOCTs available, including 
RESCAN 700 (Carl Zeiss Meditec, Inc., Oberkochen, Germany), the EnFocus (Bioptigen/Leica 
Microsystems, Wetzlar, Germany), and an integrated prototype internally developed at the 
Cole Eye Institute, Cleveland Clinic Foundation (Cleveland, Ohio) [6]. All these systems allow a 
real-time OCT imaging during the surgery and provide instantaneous feedback to the surgeon.
The PIONEER and the Determination of Feasibility of Intraoperative Spectral-Domain 
Microscope Combined/Integrated OCT Visualization during En Face Retinal and Ophthalmic 
Surgery (DISCOVER) studies have largely demonstrated the iOCT usefulness in the anterior 
and posterior segment surgery [5, 6]. Surgical procedures and pathologies positively affected 
by iOCT introduction in surgical practice include Descemet stripping automated endothelial 
keratoplasty (DSAEK), Descemet membrane endothelial keratoplasty (DMEK), pars plana vit-
rectomy for epiretinal membrane, proliferative diabetic retinopathy (PDR), rhegmatogenous 
retinal detachment, macular hole, optic pit maculopathy, chorioretinal biopsy, and Argus 
(Second Sight Medical Products, Inc., Sylmar, CA) prosthesis implant [5–13]. The DISCOVER 
study’s 3-year results have been recently published [6]. A total of 837 eyes (244 anterior seg-
ment/593 posterior segment cases) were included and iOCT successful image acquisition was 
achieved in 820 eyes (98.0%; 95% confidence interval (CI), 96.8–98.8%). In 43.4% of the anterior 
segment cases (95% CI, 37.1–49.9%) and 29.2% (95% CI, 25.5–33.0%), the surgeons considered 
that the iOCT information impacted their surgical decision-making and altered the previous 
related procedure. Thus, iOCT could be considered a useful technology for ophthalmic surgery. 
Nevertheless, there are some limitations. The RESCAN 700, the commonest iOCT, is a SD-OCT 
system with scanning speed of 27,000 A-scans per second, with a wavelength of 840 nm, refresh 
rate from 5 to 50 Hz, axial resolution of 5.5 μm in tissue, scan depth of 2 mm, and scan length of 
6 mm (adjustable from 3 to 16 mm). This means that image quality is still far away from the OCT 
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currently used in clinical practice with axial resolutions of 1 μm and scanning speed of 400,000 
A-scans per second. Furthermore, the autofocus and tracking mechanism must be improved 
to be faster and more accurate. Other limitations include artifacts, instrument shadow during 
surgery, and function overload with the surgical microscope pedal [6]. Instrument shadow is 
an important problem limiting the possibility of viewing retinal tissues immediately below the 
surgical instrument and is related to OCT image caption properties and the materials currently 
used in vitreo-retinal surgery (Figure 1). Nevertheless, new non-metallic instruments made 
from “OCT-friendly” materials, such as silicone, polycarbonate, and PVC, may allow one to 
diminish this problem, especially important in vitreo-retinal interface procedures [14, 15]. A 
valid alternative could be the use of OCT-integrated surgical instruments [14].
3. Proliferative vitreoretinopathy (PVR)
PVR is a complex process involving several risk factors, most of them still unknown. During the 
last 25 years, and despites the enormous advantages in vitreo-retinal surgery techniques, such 
as small-gauge instrumentation and new imaging technology, PVR incidence is unchanged and 
functional and anatomical results are still very poor. PVR is a complex and multifactorial disease, 
and pharmacological strategies (including anti-inflammatory drugs, antiproliferative agents, 
antineoplastic, antigrowth factors, and antioxidants) have been considered ineffective and they 
have been basically abandoned in current practice. Its pathogenesis is divided into several steps: 
migration of cells, mostly retinal pigment epithelial (RPE) and glial cells; proliferation of these 
cells; membrane development; contraction of the fibrocellular membrane; extracellular colla-
gen production; and creation of fixed folds in the retina [4]. Several cytokines, growth factors, 
and single-nucleotide polymorphisms in genes related with inflammation and apoptosis have 
shown to have a crucial role in PVR development [4, 16–24]. The histopathology of the disease is 
Figure 1. Instrument shadow during intraoperative OCT (iOCT) imaging. Note the shadow (arrow) below the vitreotome 
probe. Image obtained with the Zeiss Rescan® 700 iOCT (Carl Zeiss Meditec, Oberkochen, Germany).
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characterized by various grades of fibrocellular membrane proliferation with prominent Muller 
cell activation. These phenomena result in complete retinal architecture alteration with a loss of 
normal retinal cell organization and function. These membranes may be epi-, intra- or sub-reti-
nal. One of the crucial points is a correct and widely accepted classification which must include 
intraretinal status [4, 25]. In fact, PVR is characterized by epiretinal, subretinal but also intrareti-
nal proliferation [4, 26, 27]. Intraretinal membranes are especially important because there is no 
way to remove them during surgery [4], and this increases the risk of surgical failure due to the 
retinal shortening. Intraretinal PVR must be considered the most severe form in which changes 
affecting retinal architecture lead to significant dysfunction. Epiretinal or subretinal membranes 
can be quite easily removed during surgery but intraretinal forms are an unsolved problem. In 
this sense, iOCT may be awfully valuable in surgical practice allowing the intraoperative assess-
ment of retinal status. The iOCT may be useful to identify intraretinal changes and/or subretinal 
PVR membranes which cannot be removed with standard techniques (Figure 2). This means that 
it allows a better PVR classification and this can change our surgical attitude intraoperatively 
for better decision-making about a surgical technique. In fact, trying to remove the presumed 
membrane can have as consequences severe retinal injury and iatrogenic tears. Thus, surgical 
technique and even tamponade choice may be seriously affected by iOCT imaging.
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Figure 2. Intraoperative OCT (iOCT) in PVR. iOCT allows intraretinal changes identification (arrows). These membranes 
cannot be surgically removed. Image obtained with the Zeiss Rescan® 700 iOCT (Carl Zeiss Meditec, Oberkochen, Germany).
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